A. Vidalpuig et al., HYPERINSULINEMIA IN POLYCYSTIC-OVARY-SYNDROME - RELATIONSHIP TO CLINICAL AND HORMONAL FACTORS, The Clinical investigator, 72(11), 1994, pp. 853-857
We analyzed the association between hyperandrogenism and hyperinsuline
mia, and their relationship to body mass index, in a large series of p
atients with polycystic ovary syndrome (PCOS). A characteristic hormon
al profile was sought in women with marked hyperinsulinemia. The patie
nt group consisted of 73 women with PCOS, ranging in age from 16 to 29
years. The control group consisted of 34 healthy women with no eviden
ce of hyperandrogenism, aged 19-30 years. None of the patients or cont
rol women had a body mass index above 27 kg/m(2). Follicle-stimulating
hormone, luteinizing hormone, prolactin, testosterone, estradiol, and
rostenedione, dehydroepiandrosterone sulfate, sex hormone binding glob
ulin, 17-hydroxy-progesterone, and free cortisol were determined by ra
dioimmunoassay. The free testosterone index was calculated. The oral g
lucose tolerance test was used to analyze basal insulinemia, maximum i
nsulin peak, and the insulinemia/glycemia index. In the group with PCO
S body mass index was greater, free testosterone index was higher, and
levels of dehydroepiandrosterone sulfate, testosterone, 17-hydroxypro
gesterone (P < 0.001) and androstenedione (P < 0.05) were higher than
in the control group. Of the insulin parameters, basal insulinemia, ma
ximum insulin peak, and insulinemia/glycemia index were higher in the
patient group (P < 0.001). In patients with marked insulinemia, free t
estosterone index was more markedly elevated, and gonadotrophin levels
were normal. Our data,confirm that a characteristic pattern of hyperi
nsulinemia is associated with PCOS. We found no causal relationship be
tween hyperinsulinemia and androgen levels. A characteristic hormonal
pattern was found in patients with marked hyperinsulinemia.